• Belov, V., Guehl, N. J., Duvvuri, S., Iredale, P., Moon, S.-H., Dhaynaut, M., Chakilam, S., MacDonagh, A. C., Rice, P. A., Yokell, D. L., Renger, J. J., El Fakhri, G., & Normandin, M. D. (2024). PET imaging of M4 muscarinic acetylcholine receptors in rhesus macaques using [11C]MK-6884: Quantification with kinetic modeling and receptor occupancy by CVL-231 (emraclidine), a novel positive allosteric modulator. Journal of Cerebral Blood Flow & Metabolism, 44(8), 1329–1342.

    https://journals.sagepub.com/doi/10.1177/0271678X241238820

  • Bodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., Hurley, D. J., Potter, W. Z., & Paul, S. M. (1997). Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease. Archives of Neurology, 54(4), 465–473.

    https://jamanetwork.com/journals/jamaneurology/article-abstract/594526

  • Duvvuri, S., Iredale, P., Belov, V., Guehl, N., Moon, S.-H., & Dhaynaut, M. (2021). Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 Using [11C]MK-6884 PET in Non-Human Primates.

    https://pmc.ncbi.nlm.nih.gov/articles/PMC11342722/

  • Duvvuri, S., Iredale, P., Pin, S., Smith, D., Zhang, J., Giugliano, A., & Koole, M. (2024, April). Evaluation of M4 Muscarinic Receptor Occupancy by Emraclidine Using [11C]MK-6884 PET in Healthy Volunteers. 2024 Annual Congress of the Schizphrenia Society.

    https://pubmed.ncbi.nlm.nih.gov/38477292/

  • Gollapelli, K. K., Krizan, I., Bhoopal, B., Damuka, N., Moriarty, C., Miller, M., Sai, K. K. S., & Gould, R. W. (2025). [11C]MK-6884 PET imaging reveals lower M4 muscarinic acetylcholine receptor availability following cocaine self-administration in male rats. Pharmacological Reports, 77(2), 532–541.

    https://link.springer.com/article/10.1007/s43440-025-00695-9

  • Li, W., Wang, Y., Lohith, T. G., Zeng, Z., Tong, L., Mazzola, R., Riffel, K., Miller, P., Purcell, M., Holahan, M., Haley, H., Gantert, L., Hesk, D., Ren, S., Morrow, J., Uslaner, J., Struyk, A., Wai, J. M.-C., Rudd, M. T., … Basile, A. S. (2022). The PET tracer [11C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease. Science Translational Medicine, 14(627).

    https://pubmed.ncbi.nlm.nih.gov/35020407/

  • Marin, T., Belov, V., Chemli, Y., Ouyang, J., Najmaoui, Y., Fakhri, G. E., Duvvuri, S., Iredale, P., Guehl, N. J., Normandin, M. D., & Petibon, Y. (2025). PET Mapping of Receptor Occupancy Using Joint Direct Parametric Reconstruction. IEEE Transactions on Biomedical Engineering, 72(3), 1057–1066.

    https://pubmed.ncbi.nlm.nih.gov/39446540/

  • Masdeu, J., Pascual, B., Zanotti-Fregonara, P., Yu, M., Funk, Q., Arbones, V., Rockers, E., Wang, Y., Li, W., Cheng, A., Anderson, M., Hostetler, E., & Basile, A. (2020). [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer’s Disease: Comparison with [18F]FDG PET (2640). Neurology, 94(15_supplement), 2640.

    https://www.neurology.org/doi/10.1212/WNL.94.15_supplement.2640

  • Pascual, B., Zanotti-Fregonara, P., Yu, M., Funk, Q., Arbones, V., Wang, Y., Li, W., Cheng, A., Anderson, M., Hostetler, E., Basile, A., & Masdeu, J. (2021). [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer’s Disease: Comparison with [18F]FDG PET (4241). Neurology, 96(15_supplement), 4241.

    https://www.neurology.org/doi/10.1212/WNL.96.15_supplement.4241

  • Shekhar, A., Potter, W. Z., Lightfoot, J., Lienemann, J., Dubé, S., Mallinckrodt, C., Bymaster, F. P., McKinzie, D. L., & Felder, C. C. (2008). Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia. American Journal of Psychiatry, 165(8), 1033–1039.

    https://psychiatryonline.org/doi/10.1176/appi.ajp.2008.06091591

  • Tong, L., Li, W., Lo, M. M.-C., Gao, X., Wai, J. M.-C., Rudd, M., Tellers, D., Joshi, A., Zeng, Z., Miller, P., Salinas, C., Riffel, K., Haley, H., Purcell, M., Holahan, M., Gantert, L., Schubert, J. W., Jones, K., Mulhearn, J., … Mazzola, R. (2020). Discovery of [11 C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases. Journal of Medicinal Chemistry, 63(5), 2411–2425.

    https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01406